BioTech Medics, Inc.
BMCS
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.07K
Close$
$0.00
0% upside
Current Fair Value
0% upsideOvervalued by 0% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $41,071.00 |
|---|---|
| Enterprise Value | $43,373.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 3.66 |
| Outstanding Shares | 202,356,178 |
Return
| Return on Equity | 0.01% |
|---|---|
| Return on Assets | 0.01% |
| Return on Invested Capital | 0.01% |
Valuation & Multiples
| P/E Ratio | -13.86 |
|---|---|
| PEG | 18.94 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 6.94 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioTech Medics, Inc.
0
CEO: Anthony Keith Miller BioTech Medics, Inc. operates as a holding company with a focus on the medical field. The firm manages therapeutic laser clinics that deliver treatment for diverse pain conditions impacting muscles, nerves, bones, and arthritic discomfor...